2017
DOI: 10.15406/mojpb.2017.05.00157
|View full text |Cite
|
Sign up to set email alerts
|

Intrinsically Disordered Proteins as Drug Targets

Abstract: Intrinsically disordered proteins (IDPs) are characterized by a lack of folded structure. Since their identification more than a decade ago, they were designed as potential drug targets. However, nowadays, only few therapeutic molecules have been designed against them. Due to the nature of these proteins bioinformatics methods could have a key role disentangling IDPs related issues, which is key to design new therapeutic agents against them.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 56 publications
0
4
0
Order By: Relevance
“…K i = 1.02 μM, 0.60 μM, 0.39 μM and 0.32 μM, respectively (entries 1,5,11,16). The same correlation applies to the osubstituted halogens (o-F < o-Cl < o-Br < o-I), giving even higher binding affinities (K i = 0.74 μM, 0.36 μM, 0.07 μM and 0.05 μM, respectively (entries 3,7,13,18)). Clearly, these trends show a size-dependent activity, driven by the σ-hole, relationship being in accordance with literature [47,49].…”
Section: Probe Of Leu26 and Induced Pocketmentioning
confidence: 73%
See 2 more Smart Citations
“…K i = 1.02 μM, 0.60 μM, 0.39 μM and 0.32 μM, respectively (entries 1,5,11,16). The same correlation applies to the osubstituted halogens (o-F < o-Cl < o-Br < o-I), giving even higher binding affinities (K i = 0.74 μM, 0.36 μM, 0.07 μM and 0.05 μM, respectively (entries 3,7,13,18)). Clearly, these trends show a size-dependent activity, driven by the σ-hole, relationship being in accordance with literature [47,49].…”
Section: Probe Of Leu26 and Induced Pocketmentioning
confidence: 73%
“…Drug discovery remains slow, expensive and unreliable. Although immense progress in individual whole genome sequencing for personalized medicine has provided a wealth of novel drug targets, very few small molecule drugs for post-genomic identified targets are currently in development [1][2][3]. A major hurdle to the efficient and fast generation of novel drugs is the slow and traditional approach performed in early drug discovery and development.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…These membraneless condensates would either act as a signaling platform to activate oncogenic pathways or assemble as transcriptional complexes to promote oncogenic gene expression, both of which could result in carcinogenesis (52)(53)(54)(55). Therefore, the discovery of drugs to disrupt multivalent protein-protein interactions would be an excellent choice to disassemble aberrant biocondensates and block tumor signal transduction for anticancer effects (56,57). Cluster 3 was related to the role of DNA and RNA elements in phase separation-related diseases; it covered the keywords of chromatin, enhancer elements, neurodegenerative diseases, RNA-binding protein, RNA, disease, and gene expression regulation.…”
Section: Abstract and Future Hotspotsmentioning
confidence: 99%